Instil Bio, Inc. Accumulated Other Comprehensive Income
Instil Bio, Inc. (TIL) had Accumulated Other Comprehensive Income of -$587.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$587.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$532.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$583.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$612.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$587.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$532.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$583.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$612.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$805.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$451.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$228.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$520.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$627.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$563.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$348.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | -$525.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$795.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$406.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$493.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$335.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$557.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$441.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$87.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$104.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$210.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$253.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$283.00K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |